Online citations, reference lists, and bibliographies.
← Back to Search

An Intra-articular Salmon Calcitonin-based Nanocomplex Reduces Experimental Inflammatory Arthritis.

S. Ryan, Jason McMorrow, A. Umerska, H. Patel, K. N. Kornerup, L. Tajber, E. Murphy, M. Perretti, O. Corrigan, D. Brayden
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Prolonged inappropriate inflammatory responses contribute to the pathogenesis of rheumatoid arthritis (RA) and to aspects of osteoarthritis (OA). The orphan nuclear receptor, NR4A2, is a key regulator and potential biomarker for inflammation and represents a potentially valuable therapeutic target. Both salmon calcitonin (sCT) and hyaluronic acid (HA) attenuated activated mRNA expression of NR4A1, NR4A2, NR4A3, and matrix metalloproteinases (MMPs) 1, 3 and 13 in three human cell lines: SW1353 chondrocytes, U937 and THP-1 monocytes. Ad-mixtures of sCT and HA further down-regulated expression of NR4A2 compared to either agent alone at specific concentrations, hence the rationale for their formulation in nanocomplexes (NPs) using chitosan. The sCT released from NP stimulated cAMP production in human T47D breast cancer cells expressing sCT receptors. When NP were injected by the intra-articular (I.A.) route to the mouse knee during on-going inflammatory arthritis of the K/BxN serum transfer model, joint inflammation was reduced together with NR4A2 expression, and local bone architecture was preserved. These data highlight remarkable anti-inflammatory effects of sCT and HA at the level of reducing NR4A2 mRNA expression in vitro. Combining them in NP elicits anti-arthritic effects in vivo following I.A. delivery.
This paper references
10.1016/j.joca.2009.08.004
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
M. Karsdal (2010)
10.1038/nprot.2007.173
Collagen-induced arthritis
D. Brand (2007)
10.4049/jimmunol.175.1.555
Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses1
Jennifer A. Ralph (2005)
10.1016/j.ijpharm.2011.08.046
Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Hua-ding Lu (2011)
10.1016/J.JOCA.2006.01.014
Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes.
B. Sondergaard (2006)
10.1074/jbc.M502606200
Induction of NR4A Orphan Nuclear Receptor Expression in Macrophages in Response to Inflammatory Stimuli*
L. Pei (2005)
10.1093/RHEUMATOLOGY/KEI171
Chondroprotective drugs in degenerative joint diseases.
G. Verbruggen (2006)
10.1080/1061186042000207011
Study on the Role of 5-fluorouracil in the Polymerization of Butylcyanoacrylate during the Formation of Nanoparticles
M. Simeonova (2004)
10.3181/0708-MR-231
Nuclear Receptors and Inflammatory Diseases
K. Wang (2008)
10.1136/vr.161.18.611
Retrospective study of the effect of intra-articular treatment of osteoarthritis of the distal tarsal joints in 51 horses
R. Labens (2007)
10.1002/ART.22075
Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis.
D. Manicourt (2006)
10.1136/annrheumdis-2011-201180
The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis
H. Patel (2012)
10.1016/j.actbio.2012.08.033
Injectable chitosan hyaluronic acid hydrogels for cartilage tissue engineering.
Hyejin Park (2013)
10.1002/JPS.20341
Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits.
L. S. Liang (2005)
10.1210/ME.2005-0331
Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77.
L. Pei (2006)
10.1007/s11095-012-0870-x
Nanoparticles for Improved Local Retention after Intra-Articular Injection into the Knee Joint
M. Morgen (2012)
Arthroscopic evaluation of chondropathy in osteoarthritis of the knee.
X. Ayral (1996)
10.1186/1471-2474-11-62
Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes
B. Sondergaard (2010)
10.1038/nrd1693
Osteoarthritis — an untreatable disease?
H. A. Wieland (2005)
10.1016/J.ADDR.2006.01.018
Intraarticular drug delivery in osteoarthritis.
N. Gerwin (2006)
10.1136/ARD.2004.022434
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
I. Tchetverikov (2005)
10.1074/jbc.M608327200
Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage*
K. Mix (2007)
10.1002/art.24096
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.
X. Chevalier (2009)
10.1002/14651858.CD005321.PUB2
Viscosupplementation for the treatment of osteoarthritis of the knee.
N. Bellamy (2005)
10.1002/jbmr.1602
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
N. Binkley (2012)
10.1038/clpt.2011.278
Biologics‐Based Therapy for the Treatment of Rheumatoid Arthritis
D. Scott (2012)
10.1073/PNAS.0501215102
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.
S. B. Fowler (2005)
10.1042/BST0390688
Inflammation: a role for NR4A orphan nuclear receptors?
Jason P McMorrow (2011)
10.1002/art.33504
Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway.
M. M. Matzelle (2012)
10.1038/nrrheum.2010.179
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis
J. Hoes (2010)
Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells.
Colby A. Wyatt (2002)
10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.0.CO;2-H
Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
E. Murphy (2001)
10.1038/nri2748
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
C. Glass (2010)
10.1046/j.1533-2500.2002.02042.x
Epidural Calcitonin: Does it Provide Better Postoperative Analgesia? An Analysis of the Haemodynamic, Endocrine, and Nociceptive Responses of Salmon Calcitonin and Opioids in Epidural Anesthesia for Hip Arthroplasty Surgery
Z. Gabopoulou (2002)
10.1007/BF02555844
Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study
G. Lyritis (2007)
10.1210/MEND.11.1.9874
Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors.
E. P. Murphy (1997)
10.1016/j.drudis.2011.01.004
Recent progress toward biomarker identification in osteoarthritis.
F. De Ceuninck (2011)
10.1007/s00296-012-2399-z
Effects of calcitonin on knee osteoarthritis and quality of life
M. Esenyel (2012)
10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S
Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?
J. A. Mengshol (2002)
10.1002/14651858.CD005328.PUB2
Intraarticular corticosteroid for treatment of osteoarthritis of the knee.
N. Bellamy (2006)
10.1016/j.ijpharm.2012.07.011
Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
A. Umerska (2012)
10.1016/j.tvjl.2010.09.019
Intra-articular drug delivery: the challenge to extend drug residence time within the joint.
S. Edwards (2011)
10.1002/0471142735.im1500s96
Animal Models for Autoimmune and Inflammatory Disease
E. Shevach (2008)
10.1517/14728214.2011.576670
Emerging drugs for osteoarthritis
G. Matthews (2011)
10.1080/10611860400010630
Celecoxib Incorporated Chitosan Microspheres: In Vitro and In Vivo Evaluation
H. Thakkar (2004)
10.1161/01.ATV.0000238346.84458.5d
Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses
P. Bonta (2006)
10.1023/A:1015123024113
Prolonged Anti-Inflammatory Action of DL-Lactide/Glycolide Copolymer Nanospheres Containing Betamethasone Sodium Phosphate for an Intra-Articular Delivery System in Antigen-Induced Arthritic Rabbit
E. Horisawa (2004)
10.1517/14656566.9.10.1797
Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis
T. Conrozier (2008)
10.1007/s10067-009-1357-y
Local effects of intra-articular corticosteroids
G. Habib (2009)
10.1002/jor.21240
Intra‐articular injection of hyaluronan restores the aberrant expression of matrix metalloproteinase‐13 in osteoarthritic subchondral bone
N. Hiraoka (2011)
10.1016/j.jconrel.2008.12.014
Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate.
S. Ryan (2009)
10.1002/art.34399
Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription.
K. Mix (2012)
10.3233/BME-2010-0637
Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees.
Hervé Zille (2010)
10.1210/ME.2007-0169
Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle.
L. Chao (2007)
10.1517/17425240802647259
Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy
H. Burt (2009)
10.1007/s10067-009-1135-x
Systemic effects of intra-articular corticosteroids
G. Habib (2009)
10.1007/BF02555899
Chondroprotective action of salmon calcitonin in experimental arthropathies
J. Badurski (2007)
10.5694/j.1326-5377.1981.tb128316.x
PAGET'S DISEASE OF BONE EXPERIENCES WITH 100 PATIENTS TREATED WITH SALMON CALCITONIN ∗
H. Grunstein (1981)
10.1634/THEONCOLOGIST.9-5-571
Adjuvant analgesics in cancer pain management.
D. Lussier (2004)
10.1002/ART.10212
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.
P. Koshy (2002)
10.1007/s00198-011-1676-0
Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis
J. A. Knopp-Sihota (2011)
10.1007/978-1-61779-561-9_19
K/BxN serum transfer arthritis as a model of inflammatory joint pain.
C. Christianson (2012)
10.1002/ART.10547
Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.
K. Masuhara (2002)
10.1080/08982100701557129
Biodistribution and Clearance of Intra-articular Liposomes in a Large Animal Model Using a Radiographic Marker
Scott R. Edwards (2007)
10.1002/art.27238
Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1.
P. Monach (2010)



This paper is referenced by
10.1016/j.coph.2014.09.019
Progress in the delivery of nanoparticle constructs: towards clinical translation.
S. Ryan (2014)
10.1016/j.jconrel.2014.05.014
Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics.
K. Ganguly (2014)
NR 4 A 2 Expression Patterns in Mouse Models of Rheumatoid Arthritis
Jordan R Everett (2015)
10.1016/j.carbpol.2015.01.066
Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics.
M. Dul (2015)
10.1016/J.IFSET.2017.07.002
Comparative study of the structural and physicochemical properties of two food derived antihypertensive tri-peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline encapsulated into a chitosan based nanoparticle system
Minna K. Danish (2017)
10.1007/s11926-020-0884-z
Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities
R. Mohammadinejad (2020)
10.1016/j.ajps.2017.12.007
Intra-articular delivery of tetramethylpyrazine microspheres with enhanced articular cavity retention for treating osteoarthritis
Xiuping Zhang (2018)
10.1016/J.TIFS.2016.05.007
Oral delivery strategies for nutraceuticals: Delivery vehicles and absorption enhancers
J. P. Gleeson (2016)
10.2174/1381612825666190708184745
Targeting Polymeric Nanobiomaterials as a Platform for Cartilage Tissue Engineering.
J. García-Couce (2019)
10.3892/ijmm.2019.4398
NR4A1 promotes TNF-α-induced chondrocyte death and migration injury via activating the AMPK/Drp1/mitochondrial fission pathway
Zhibo Zheng (2019)
10.3390/POLYM6030799
Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities
M. Janssen (2014)
10.1016/j.ijpharm.2014.10.023
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
A. Umerska (2014)
10.3390/pharmaceutics12030259
An Enteric-Coated Polyelectrolyte Nanocomplex Delivers Insulin in Rat Intestinal Instillations When Combined with a Permeation Enhancer
Svenja Sladek (2020)
10.47611/jsr.v4i1.213
NR4A2 Expression Patterns in Mouse Models of Rheumatoid Arthritis
Jordan R Everett (2015)
10.1007/978-3-319-16104-4
The Impact of Food Bioactives on Health
K. Verhoeckx (2015)
10.1166/JBN.2014.1878
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)
10.1136/annrheumdis-2013-204111
The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
M. Karsdal (2014)
10.1080/21691401.2018.1460373
Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment
Sana Pirmardvand Chegini (2018)
10.3109/1061186X.2013.832769
Multifunctional nanoparticles for targeting cancer and inflammatory diseases
S. Jain (2013)
10.3389/fimmu.2016.00213
K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis
A. D. Christensen (2016)
10.1007/978-1-4939-9195-2_3
Subcellular Localization of NR4A2 Orphan Nuclear Receptor Expression in Human and Mouse Synovial Joint Tissue.
A. Smyth (2019)
10.1021/acsami.7b05740
Calcitonin-Loaded Thermosensitive Hydrogel for Long-Term Antiosteopenia Therapy.
Yanpeng Liu (2017)
10.1007/s10439-016-1600-z
Osteoarthritis: Pathology, Mouse Models, and Nanoparticle Injectable Systems for Targeted Treatment
Derek T. Holyoak (2016)
10.1039/C8TB02812E
Recent advances in functional nanostructured materials for bone-related diseases.
Anqi Li (2019)
10.1002/jps.23924
Fabrication of biocompatible and tumor-targeting hyaluronan nanospheres by a modified desolvation method.
Wenyi Zheng (2014)
10.1016/j.jconrel.2019.04.042
Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis.
Yanpeng Liu (2019)
10.1126/scitranslmed.aac5608
Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis
S. Headland (2015)
10.1007/s11926-013-0385-4
The Future of Osteoarthritis Therapeutics: Emerging Biological Therapy
A. Mobasheri (2013)
10.1007/s13346-018-0557-x
Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation
Svenja Sladek (2018)
10.21608/ejh.2019.7235.1068
Comparative Histological Study between the Effect of Calcitonin versus Hormonal Replacement Therapy on Cartilage of Knee Joint of Ovariectomized Albino Rat
Faten Riad Osman (2019)
10.1016/j.jddst.2020.102011
Nanotechnology application in drug delivery to Osteoarthritis (OA), Rheumatoid arthritis (RA), and Osteoporosis (OSP)
M. Rabiei (2020)
10.1016/j.ijpharm.2018.09.035
Freeze drying of polyelectrolyte complex nanoparticles: Effect of nanoparticle composition and cryoprotectant selection
A. Umerska (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar